Possible Predictors of Mortality Based on COVID-19 for Patients Under 50 Years Old: A Multi-Center Experience of Istanbul

Completed

• Conditions: Covid-19; Risk Factor, Mortality

• Registration Number: NCT04479137
• Lead Sponsor: Kanuni Sultan Suleyman Training and Research Hospital

Brief Summary

COVID-19, which emerged in China in December 2019, has become a pandemic with its spread to many countries of the world. Mortality rates of COVID-19 pandemics vary between countries. It is known that mortality based on COVID-19 is higher in old population. Therefore the aim of this study to analyze the experience of 7 governmental hospitals in terms of patient characteristics, possible risk factors of mortality based on COVID-19.

Detailed Description

COVID-19, which emerged in China in December 2019, has become a pandemic with its spread to many countries of the world. Mortality rates of COVID-19 pandemics vary between countries. It is known that mortality based on COVID-19 is higher in old population. Although several factors defined to be effective on this 'age depending factors' regional differences should be assessed deeply to clarify both the etiology and epidemiology. Therefore the aim of this study to analyze the experience of 7 governmental hospitals in terms of patient characteristics, possible risk factors of mortality based on COVID-19.

Study Timeline

• Study Start: 2020-03-10
• Primary Completion: 2020-06-30
• Status Verified: 2020-07
• Study Completion: 2020-07-14
• Study First Submitted: 2020-07-18
• Study First Submitted QC: 2020-07-19
• Last Update Submitted: 2020-07-20
• Study First Posted: 2020-07-21
• Last Update Posted: 2020-07-22

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 5000

Inclusion Criteria

• accepted to participate
• patients who were proven to have COVID-19

Read More

Exclusion Criteria

• declined to participate
• patients whose age under 18 or more than 50 years

Read More

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
mortality based on COVID-19	3 months	mortality based on COVID-19 within the patients aged between 18-50 will be evaluated

Trial Locations

Locations (1)

Kanuni Sultan Suleyman Training and Research Hospital; 🇹🇷 Istanbul, Turkey